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Adult skeletal muscle possesses a remarkable regenerative ability that is dependent
on satellite cells. However, skeletal muscle is replaced by fatty and fibrous connective
tissue in several pathological conditions. Fatty and fibrous connective tissue becomes a
major cause of muscle weakness and leads to further impairment of muscle function.
Because the occurrence of fatty and fibrous connective tissue is usually associated
with severe destruction of muscle, the idea that dysregulation of the fate switch in
satellite cells may underlie this pathological change has emerged. However, recent
studies identified nonmyogenic mesenchymal progenitors in skeletal muscle and revealed
that fatty and fibrous connective tissue originates from these progenitors. Later, these
progenitors were also demonstrated to be the major contributor to heterotopic ossification
in skeletal muscle. Because nonmyogenic mesenchymal progenitors represent a distinct
cell population from satellite cells, targeting these progenitors could be an ideal
therapeutic strategy that specifically prevents pathological changes of skeletal muscle,
while preserving satellite cell-dependent regeneration. In addition to their roles in
pathogenesis of skeletal muscle, nonmyogenic mesenchymal progenitors may play a vital
role in muscle regeneration by regulating satellite cell behavior. Conversely, muscle cells
appear to regulate behavior of nonmyogenic mesenchymal progenitors. Thus, these cells
regulate each other reciprocally and a proper balance between them is a key determinant
of muscle integrity. Furthermore, nonmyogenic mesenchymal progenitors have been
shown to maintain muscle mass in a steady homeostatic condition. Understanding
the nature of nonmyogenic mesenchymal progenitors will provide valuable insight into
the pathophysiology of skeletal muscle. In this review, we focus on nonmyogenic
mesenchymal progenitors and discuss their roles in muscle pathogenesis, regeneration,
and homeostasis.
Keywords: mesenchymal progenitors, satellite cells, PDGFRα, adipogenesis, fibrosis, heterotopic ossification,
muscle regeneration, muscle atrophy
INTRODUCTION
The most fundamental roles of skeletal muscle are the genera-
tion of force and the control of body movement by contraction.
In addition, skeletal muscle serves as physical safeguard for other
organs as it is anatomically located immediately beneath the skin.
Because of its functional roles, skeletal muscle represents one
of the most frequently damaged organs in the body. Therefore,
regeneration from the damage is an essential property of skele-
tal muscle. One of the best examples of remarkable regeneration
capacity of skeletal muscle is the study that showed myofiber
regeneration after more than 20 repeated injuries (Sadeh et al.,
1985). The high regeneration capacity of skeletal muscle is
attributed to satellite cells, which reside between the sarcolemma
and the basal lamina of myofibers. M-cadherin and Pax7 are
the most reliable markers for mouse satellite cells (Irintchev
et al., 1994; Seale et al., 2000). An essential role for satellite
cells in adult myogenesis was exquisitely demonstrated by stud-
ies using genetically-engineered mice in which Pax7-expressing
satellite cells are ablated (Lepper et al., 2011; Murphy et al., 2011;
Sambasivan et al., 2011). These mice showed complete loss of
regenerative response and severe fatty and fibrous degeneration
after muscle injury, indicating that nonsatellite cells cannot com-
pensate for satellite cell-dependent myogenesis. In addition to
contributing to new myofiber formation, a subset of satellite cells
have been shown to be capable of self-renewal (Collins et al., 2005;
Montarras et al., 2005; Sacco et al., 2008; Rocheteau et al., 2012).
Thus, satellite cells act as adult muscle stem cells.
Despite the presence of well-established stem cells that under-
lie the exceptional regeneration potential, skeletal muscle is
replaced by ectopic tissues such as adipose tissue, fibrous con-
nective tissue, and bone in several pathological conditions. These
ectopic tissues become an aggravating factor in muscle weak-
ness because they lack contractile ability and hinder the supply
of nutrients to myofibers. In most cases, ectopic tissue forma-
tion within skeletal muscle is associated with severe destruction
of myofibers, leading to the concept that dysregulation of the fate
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switch in satellite cells may underlie these degeneration processes.
However, this concept was refuted by recent studies describing the
identification of nonmyogenic mesenchymal progenitors in skele-
tal muscle. These studies established the pathological relevance
of nonmyogenic mesenchymal progenitors to muscle diseases. In
addition to their roles in disease conditions, nonmyogenic mes-
enchymal progenitors appear to play roles in muscle regeneration
and in steady-state muscle homeostasis. This review focuses on
nonmyogenic mesenchymal progenitors and describes their roles
in the pathogenesis, regeneration, and homeostasis of skeletal
muscle.
FAT INFILTRATION, FIBROSIS, AND HETEROTOPIC
OSSIFICATION IN SKELETAL MUSCLE
In normal healthy muscle, especially in the gastrocnemius, occa-
sional adipocytes can be encountered in connective tissue septa
(Carpenter and Karpati, 2001). Physiological significance of these
occasional adipocytes in normal muscle is largely unknown.
Disease in which there is loss of muscle cells without efficient
regeneration leads to an increase of ectopic adipocytes within
fascicles (Carpenter and Karpati, 2001). In myopathic disor-
ders accompanied by myofiber destruction, endomysial fibrous
connective tissue increases from the onset of the disease, but
the increase in endomysial fatty connective tissue is observed
only after there has been an extensive loss of myofibers (Banker
and Engel, 2004). The most striking accumulation of adipocytes
is seen in advanced cases of Duchenne muscular dystrophy
(DMD) or myotonic dystrophy, where a muscle may be almost
entirely replaced by adipose tissue (Carpenter and Karpati, 2001;
Banker and Engel, 2004). Fat infiltration in skeletal muscle is
also pronounced in other disease conditions including obesity
(Goodpaster et al., 2000; Greco et al., 2002; Sinha et al., 2002),
type II diabetes (Goodpaster et al., 2000; Hilton et al., 2008),
unloading (Manini et al., 2007), hemiparetic stroke (Ryan et al.,
2002), and spinal cord injury (Gorgey and Dudley, 2007). Aging
is accompanied by deterioration in muscle function, and fat
infiltration in skeletal muscle increases with age Visser et al.,
2002, 2005; Kim et al., 2009; Marcus et al., 2010; Kragstrup
et al., 2011. It is not known whether adipocytes within skele-
tal muscle would disappear if the disease conditions could be
reversed.
Fibrosis is a pathological feature associated with many chronic
inflammatory diseases. Fibrosis is defined by the excessive accu-
mulation of extracellular matrix (ECM) components, which can
lead to permanent scarring and organ malfunction. Although
ECM deposition is an indispensable and, typically, reversible part
of wound healing, the repair process can produce a progressively
irreversible fibrosis if the tissue injury is severe or repetitive or
if there is a defect in the repair machinery. Fibrosis in skeletal
muscle can be seen in most conditions where there is chronic
muscle damage or insufficient regeneration but is most promi-
nent inmuscular dystrophy (Carpenter and Karpati, 2001; Banker
and Engel, 2004). A possible exception is myotonic dystrophy,
where fat infiltration appears to proceed without much fibrosis
(Carpenter and Karpati, 2001). Sports injuries such as lacera-
tions, contusions or strains can also elicit irreversible fibrotic
response and lead to scar formation depending on the severity
of injuries (Jarvinen et al., 2000; Beiner and Jokl, 2001). Although
myofibroblasts are cells responsible for fibrosis of other organs
such as liver and kidney, one should keep in mind that these
cells have not been identified in most skeletal muscle diseases
except for nodular fasciitis (Wirman, 1976) and pseudomalignant
myositis ossificans (Povysil and Matejovsky, 1979).
Heterotopic ossification (HO) is defined as the abnormal for-
mation of mature, lamellar bone in soft tissues outside the skeletal
periosteum. The most commonly affected site is skeletal muscle.
HO has been thought to result from inappropriate differentiation
of progenitor cells that is induced by a pathological imbalance
of local or systemic factors. There are three recognized etiolo-
gies of HO: traumatic, neurogenic, and genetic (Balboni et al.,
2006). Traumatic HO is the most common type of HO and typi-
cally recognized after fractures, severe burns, and surgical trauma,
especially after total hip arthroplasty (Nilsson and Persson, 1999).
Neurogenic HO can be frequently seen after injuries to central
nervous system (Garland et al., 1980). Other neurologic con-
ditions have also been implicated in the development of HO,
including meningitis (Lorber, 1953), myelitis (Stoikovic et al.,
1955), and tetanus (Ishikawa et al., 1982). Genetic disorders in
which HO arises in skeletal muscle are fibrodysplasia ossificans
progressiva (FOP) and progressive osseous heteroplasia (POH)
(Kaplan and Shore, 2000; Pignolo et al., 2011). FOP is a severely
disabling heritable disorder of connective tissue characterized
by congenital malformations of the great toes and progressive
extraskeletal ossification. Mutation of the ALK-2 gene, a BMP
type I receptor, was identified in FOP patients (Shore et al., 2006)
and has been shown to contribute to the pathogenesis of FOP
(Chakkalakal et al., 2012). POH is a genetic disorder of mesenchy-
mal differentiation characterized by dermal ossification during
infancy and progressive HO of cutaneous, subcutaneous, and
deep connective tissues including skeletal muscle during child-
hood. An inactivating mutation of GNAS1 gene was reported to
be the cause of POH (Shore et al., 2002).
IDENTIFICATION OF NONMYOGENIC MESENCHYMAL
PROGENITORS AND THEIR CONTRIBUTION TO
PATHOGENESIS OF SKELETAL MUSCLE
To clarify the origin of cell populations involved in the fatty
degeneration of skeletal muscle, we conducted a comprehensive
survey of cells that reside in skeletal muscle using a FACS-based
cell isolation technique. As a consequence, we found that only
cells expressing PDGFRα can differentiate into adipocytes. In
addition to adipogenic potential, PDGFRα+ cells can differen-
tiate into osteoblastic or smooth muscle-like cells but scarcely
differentiate into skeletal muscle lineage cells. Therefore, we
termed these cells mesenchymal progenitors (Uezumi et al.,
2010). Mesenchymal progenitors reside in the muscle intersti-
tium and therefore represent a cell population that is distinct from
satellite cells (Figure 1). These cells are more frequently observed
in the perimysium than in the endomysium, particularly in the
perivascular space. But they are distinct from pericytes because
they reside outside the vessel wall and outside the capillary base-
ment membrane. They do not originate from bone marrow, but
instead represent a cell population that is resident in skeletal mus-
cle. Importantly, onlymesenchymal progenitors can participate in
Frontiers in Physiology | Striated Muscle Physiology February 2014 | Volume 5 | Article 68 | 2
Uezumi et al. Mesenchymal progenitors in skeletal muscle
FIGURE 1 | Localization of PDGFRα+ mesenchymal progenitors in
normal muscle. (A) Fresh frozen section of mouse TA muscle subjected to
immunofluorescence staining for M-cadherin (M-cad), PDGFRα, and laminin
α2, and subsequently to HE staining. Arrows indicate PDGFRα+
mesenchymal progenitors and arrowhead indicates satellite cells. Scale bar:
10μm. (B) Schematic view of (A). Mesenchymal progenitors that reside in
muscle interstitium express collagen VI, follistatin, and laminin α2, and
maintain muscle mass in a normal physiological condition.
ectopic fat cell formation when transplanted into fatty degenerat-
ing muscle, while other cells residing within skeletal muscle do
not have such an activity (Uezumi et al., 2010). Another group
also identified cells with adipogenic potential on the basis of Sca-
1 and CD34 expression (Joe et al., 2010). Sca-1+CD34+ cells
were referred to as fibro/adipogenic progenitors (FAPs), because
these cells have the potential to produce both adipocytes and
fibroblasts but fail to differentiate into osteogenic cells in vitro.
PDGFRα+ mesenchymal progenitors express Sca-1, and com-
plementally FAPs express PDGFRα (Joe et al., 2010; Uezumi
et al., 2010); thus both cell types seem to represent the same
cell population. Adipocytes that emerge in skeletal muscle show
unilocular morphology and PDGFRα+ cell-derived adipocytes
express high level of Leptin (Uezumi et al., 2010), indicating that
mesenchymal progenitors have a high propensity to differentiate
into white adipose lineage. However, brown adipogenic potential
of Sca-1+ progenitors was also demonstrated (Schulz et al., 2011).
Thus, mesenchymal progenitors appear to possess the capacity to
differentiate into both white and brown adipocytes.
In the subsequent study, we revealed that mesenchymal pro-
genitors also contribute to skeletal muscle fibrosis (Uezumi et al.,
2011). A striking increase in the number of PDGFRα+ cells
is conspicuous in fibrotic areas of the diaphragm from mdx
mice (Figure 2). Using an irradiation-induced muscle fibrosis
model, we further demonstrated that transplanted PDGFRα+
cells directly participate in fibrotic scar tissue formation with
negligible myogenic activity (Uezumi et al., 2011). In contrast,
satellite cell-derived myoblasts exclusively participate in myofiber
formation but do not contribute to fibrous connective tissue
formation. A study by Dulauroy et al. provided further details.
By inducible lineage tracing, Dulauroy et al. showed that a
subset of PDGFRα+ cells begin to express ADAM12 during
muscle injury and an ADAM12+PDGFRα+ subset accumu-
lates fibrotic regions of injured muscle (Dulauroy et al., 2012).
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This study sophisticatedly demonstrated that endogenous mes-
enchymal progenitors are indeed the origin of profibrotic cells.
However, the study utilized a CTX muscle injury model. Because
skeletal muscle regenerates almost completely without develop-
ment of fibrotic scar tissue after CTX injection (Hawke and
Garry, 2001; Harris, 2003), this model reflects a reversible repair
process rather than irreversible fibrosis. Therefore, the behavior
of ADAM12+PDGFRα+ cells in a more pathologically relevant
model would be of considerable interest. Using single myofibers
isolated from Pax7-CreER/ROSA26 mice, a strain in which
tamoxifen administration leads to permanent β-galactosidase
expression only in Pax7+ satellite cells, satellite cells were shown
to become fibrogenic under the influence of aged serum (Brack
et al., 2007). The conversion ratio was around 10% in this context.
In contrast, nearly 100% of PDGFRα+ mesenchymal progeni-
tors were converted to fibrogenic cells when treated with TGF-β
at a concentration that had no effect on satellite cell myogeneity
(Uezumi et al., 2011). Although different experimental conditions
used in those studies make direct comparisons difficult, mes-
enchymal progenitors seem to be more prone to fibrogenic con-
version than satellite cells. However, further studies are needed to
elucidate which cell type—satellite cells or PDGFRα+ mesenchy-
mal progenitors—is the main source of fibrogenic cells in an aged
environment in vivo. The link between fibrogenesis and PDGFRα
signaling has been demonstrated by several studies. Olson and
Soriano generated mice in which mutant PDGFRαwith increased
kinase activity was knocked into a PDGFRα locus (Olson and
Soriano, 2009). Thus, constitutively active PDGFRα signaling is
operative only in cells that express PDGFRα endogenously in
the mutant mice. The mice with mutant PDGFRα showed pro-
gressive fibrosis in multiple organs including skeletal muscle.
We showed that stimulation of PDGFRα signaling in PDGFRα+
mesenchymal progenitors promotes cell proliferation and upreg-
ulates the expression of fibrosis-related genes (Uezumi et al.,
2011). Imatinib, an inhibitor of several tyrosine kinases including
PDGFR, c-kit, and bcr-abl oncogene, was shown to ameliorate the
dystrophic symptoms of mdx mice (Bizario et al., 2009; Huang
et al., 2009; Ito et al., 2013). Importantly, imatinib treatment
decreased the phosphorylation level of PDGFRα in the dystrophic
muscle (Huang et al., 2009), and treatment of PDGFRα+ mes-
enchymal progenitors with imatinib inhibited PDGFRα-induced
proliferation and expression of fibrotic genes (Ito et al., 2013).
Taking these findings into account, the therapeutic effect of ima-
tinib exerted on dystrophic mice seems to be achieved at least in
part through targeting PDGFRα+ mesenchymal progenitors.
The contribution of mesenchymal progenitors to HO in skele-
tal muscle was exquisitely demonstrated by Goldhamer and col-
leagues. By crossing lineage-specific Cremice with Cre-dependent
reporter mice, they generated several mouse lines in which spe-
cific lineage cells were permanently labeled, and showed that
skeletal myogenic cells including satellite cells or smooth muscle
cells do not contribute to BMP-inducedHO. Instead, they found a
significant contribution of Tie2-lineage cells to HO in two mouse
models of dysregulated BMP signaling (Lounev et al., 2009). Tie2
is usually used as a marker of endothelial cells, but expression
of the Tie2 gene is also recognized in mesenchymal progeni-
tors (Uezumi et al., 2010). To clarify which cell type labeled
FIGURE 2 | The behavior of PDGFRα+ mesenchymal progenitors in
dystrophic muscle. Fresh frozen section of mdx diaphragm subjected to
immunofluorescence staining for laminin α2, PDGFRα, and collagen I, and
subsequently to HE staining. Scale bar: 20μm.
by Tie2-Cre contributes to the development of HO, Wosczyna
et al. conducted further detailed research. Although endothelial
cells constitute a large part of the Tie2+ fraction, they did not
detectably contribute to HO. After careful cell fractionation by
FACS, PDGFRα+Sca-1+ cells within Tie2+ fraction were found
to be the predominant source of progenitors that give rise to
ectopic cartilage and bone (Wosczyna et al., 2012). Clonal anal-
ysis revealed that Tie2+PDGFRα+Sca-1+ progenitors are mul-
tipotent as colonies derived from single Tie2+PDGFRα+Sca-1+
cells exhibited both osteogenic and adipogenic differentiation
potentials.
As described above, several studies independently reported
nonmyogenic mesenchymal progenitors that contribute to the
pathogenesis of skeletal muscle. Progenitor cells described
by different groups share a common cell surface pheno-
type: CD31−CD45−Sca-1+PDGFRα+, and therefore seem to be
closely related to each other or represent the same cell popula-
tion. FAPs were so named because they did not differentiate into
osteogenic cells (Joe et al., 2010). But it is obvious that these pro-
genitors possess osteo/chondrogenic potential as demonstrated
in the studies by Goldhamer and colleagues. Because osteogenic
potential of FAPs was assessed only in in vitro condition with-
out BMP (Joe et al., 2010), their differentiation potential was
probably underestimated. Therefore, the name FAPs does not rep-
resent the nature of these progenitors adequately. Although Sca-1
is widely used to identify progenitor populations in mice, it is also
highly expressed in nonprogenitor cells such as endothelial cells.
Furthermore, there is no human homolog of Sca-1 (Holmes and
Stanford, 2007). Thus, this marker lacks relevance to the patho-
physiology of human skeletal muscle. In contrast, PDGFRα is
highly specific to mesenchymal progenitors (Uezumi et al., 2010)
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and is conserved in humans. In fact, cells equivalent to mouse
PDGFRα+mesenchymal progenitors can be isolated from human
muscle using PDGFRα as the marker (Oishi et al., 2013). As we
have consistently used this marker since we described PDGFRα
as the specific marker of mesenchymal progenitors for the first
time, we believe that PDGFRα is the best marker to identify
mesenchymal progenitors in skeletal muscle.
SATELLITE CELLS: MUSCLE STEM CELLS OR MULTIPOTENT
STEM CELLS?
Although satellite cells have been considered as monopotential
precursors that give rise only to cells of myogenic lineage (Bischof,
2004), several studies have shown that satellite cells can differen-
tiate into cells of nonmyogenic lineages using satellite cell-derived
myoblast culture or single myofiber culture (Asakura et al., 2001;
Wada et al., 2002; Shefer et al., 2004). In myoblast culture, cells
are usually purified by a preplating method or by culturing
muscle-derived cells at a density that selectively promotes myo-
genic colony formation while nonmyogenic cells grow poorly.
These methods require relatively long culture periods to obtain
a pure culture. However, long-term culture or clonal expansion
can elicit spontaneous transformations that lead to generation of
the differentiation-defective cells often observed in myogenic cell
lines (Lim and Hauschka, 1984). Moreover, only a few passages
significantly reduce the muscle reconstitution ability of satellite
cells (Montarras et al., 2005; Ikemoto et al., 2007). Therefore, the
cells obtained may have undergone considerable changes during
long culture periods, and thus cannot be considered equivalent
to satellite cells. Single myofiber culture is a method to isolate
single myofibers with their associated satellite cells by appropri-
ate enzymatic treatment. Because each single myofiber carries a
small number of satellite cells (approximately 10–20 satellite cells
depending on the muscle from which the myofiber is derived)
(Collins et al., 2005), contamination with only a few nonsatellite
cells will have a considerable impact. In fact, it has been demon-
strated that all the adipocytes that emerge in a single myofiber
culture are derived from contaminated nonsatellite cells (Starkey
et al., 2011).
The studies describing nonmyogenic mesenchymal progeni-
tors showed that satellite cells do not adopt nonmyogenic fates
but exclusively contribute to myogenesis even when transplanted
into degenerating muscle that facilitate adipogenic, fibrogenic,
or osteo/chondrogenic differentiation (Uezumi et al., 2010, 2011;
Wosczyna et al., 2012). These findings suggest that satellite cells are
committed to the myogenic lineage. This was further supported
by the studies showing the expression of myogenic determination
genes in satellite cells or progenitors of satellite cells. Using lineage
tracing or selective cell ablation strategies, it has been shown that
essentially all adult satellite cells originate from progenitors that
had expressedMyoD, a keymuscle determination gene, prenatally,
and these MyoD-expressing progenitors are essential for skeletal
myogenesis and satellite cell development (Kanisicak et al., 2009;
Wood et al., 2013). Myf5, another muscle determination gene,
is expressed at the mRNA level in the majority of satellite cells,
but its translation was shown to be repressed by miR-31, leading
to a model in which posttranscriptional mechanisms hold qui-
escent satellite cells poised to enter the myogenic program (Crist
et al., 2012). Taken together, satellite cells should be considered
as muscle stem cells committed to myogenic lineage. Although
recent study showed that satellite cells can differentiate into brown
adipocytes, this differentiation pathway is inhibited by miR-133
in a physiological context (Yin et al., 2013).
ROLES FOR NONMYOGENIC MESENCHYMAL PROGENITORS
IN MUSCLE REGENERATION
The pathological relevance of nonmyogenic mesenchymal pro-
genitors to muscle diseases leads to the idea that targeting these
cells can be an excellent therapeutic strategy for the treatment of
muscle disorders. However, this idea should be considered care-
fully, because nonmyogenic mesenchymal progenitors are also
present in normal healthy muscle. In fact, we found that the
number of these cells significantly increased during the muscle
regeneration induced by CTX injection (Uezumi et al., 2010). As
described earlier, CTX injection elicits successful muscle regen-
eration that is not accompanied by fat infiltration and fibrosis.
Thus, mesenchymal progenitors decreased in number without
making fatty and fibrous connective tissue as muscle regeneration
proceeded. Intriguingly, they encircled the sheath of the basement
membrane in which satellite cells undergo active myogenesis
during muscle regeneration (Uezumi et al., 2010) (Figure 3).
These findings suggest the interaction betweenmesenchymal pro-
genitors and activated satellite cells. To gain insight into the
interaction between them, we employed a co-culture system and
found that adipogenesis of mesenchymal progenitors was strongly
inhibited by the presence of myogenic cells derived from satellite
cells (Uezumi et al., 2010). Rossi and co-workers demonstrated
the complementary effect of this interaction. They showed that
satellite cell-dependent myogenesis is promoted by mesenchymal
progenitors in the co-culture (Joe et al., 2010).
The in vivo significance of the interaction between two types
of cells was elegantly demonstrated by Kardon and colleagues.
They first found that the transcription factor Tcf4 is expressed
in lateral plate-derived limb mesodermal cells distinct from myo-
genic cells (Kardon et al., 2003). They explored the identity of
Tcf4+ cells and revealed that Tcf4 identifies connective tissue
fibroblasts that are closely associated with skeletal muscles dur-
ing development and in adulthood. By utilizing Tcf4-Cre mice,
which allow genetic manipulation of connective tissue fibroblasts,
fibroblasts were shown to promote slow myogenesis, the switch
from fetal to adult muscle, and myoblast fusion (Mathew et al.,
2011). This study clearly indicated that connective tissue fibrob-
lasts are a critical regulator of muscle development. Roles for
connective tissue fibroblasts have been further explored in adult
muscle regeneration. Tcf4+ fibroblasts were specifically ablated
using Tcf4-CreERT2 knock-in mice that allow conditional gene
manipulation in connective tissue fibroblasts. Fibroblast-ablated
mice showed impaired muscle regeneration with premature satel-
lite cell differentiation, depletion of the early pool of satellite
cells, and smaller regenerated myofibers (Murphy et al., 2011).
This was the first in vivo demonstration of the importance
of connective tissue fibroblasts as the niche regulating satellite
cell expansion during regeneration. Connective tissue fibroblasts
appear to have more impact in regulating muscle regeneration
because the ablation efficiency of Tcf4+ cells was about 40% in
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FIGURE 3 | Localization of PDGFRα+ mesenchymal progenitors in
regenerating muscle. (A) Fresh frozen section of regenerating muscle
subjected to immunofluorescence staining for M-cadherin (M-cad),
PDGFRα, and laminin α2, and subsequently to HE staining. Scale bar:
10μm. (B) Schematic view of (A). Mesenchymal progenitors encircle the
sheath of basement membrane in which satellite cells undergo active
myogenesis. Mesenchymal progenitors stimulate satellite cell expansion
and promote satellite cell-dependent myogenesis. Factors responsible for
these effects remain to be identified.
this study. The authors also showed that specific ablation of satel-
lite cells resulted in a complete loss of regenerated myofibers,
and, importantly, misregulation of fibroblasts, leading to a dra-
matic increase in fatty and fibrous connective tissue (Murphy
et al., 2011). Thus, reciprocal interaction between the two types
of cells is critical for efficient and effective muscle regenera-
tion. A direct relationship between mesenchymal progenitors and
Tcf4+ fibroblasts remains to be demonstrated. However, Tcf4+
fibroblasts express PDGFRα (Murphy et al., 2011), a marker of
mesenchymal progenitors, and accumulating evidence suggests
that mesenchymal progenitors and so-called fibroblasts share
much more in common than previously recognized (Sudo et al.,
2007; Haniffa et al., 2009). Therefore, these cells might be largely
overlapping.
Heredia et al. reported that IL-4 signaling inhibits adipogenesis
and stimulates the support function of mesenchymal progeni-
tors for successful muscle regeneration (Heredia et al., 2013).
IL-4 signaling also elicited phagocytic activity in mesenchymal
progenitors and promoted the clearance of necrotic fibers by
mesenchymal progenitors (Heredia et al., 2013). This study pro-
vided the regulatory mechanism of mesenchymal progenitors
during muscle regeneration. IL-4 is also probably best known as
the canonical Th2 effector cytokine and a critical developmen-
tal determinant that promotes Th2 response but inhibits Th1
response (Swain et al., 1990). Genetic background is known to
greatly affect the nature of the Th cell response. BALB/c and
DBA/2 mice are well known as strains with a high Th2 bias
and as high producers of IL-4, and conversely, C57BL/6 and
C57BL/10 mice are well known as the strains with low Th2 bias
and as low producers of IL-4 (Reiner and Locksley, 1995; Bix
et al., 1998; Yagi et al., 2002; Okamoto et al., 2009). Genetic
background is also known to affect muscle regeneration poten-
tial. Importantly, BALB/c and DBA/2 mice show impaired muscle
regeneration with adipocyte infiltration even in the CTX model
that never induces fatty degeneration in C57BL/6 or C57BL/10
mice (Fukada et al., 2010). Therefore, muscle regeneration abil-
ity appears to correlate inversely with IL-4 production ability.
Although self-renewal capacity of satellite cells was diminished
in DBA/2 mice (Fukada et al., 2010), it still remains a mys-
tery why high IL-4-producing strains, BALB/c and DBA/2 mice,
readily develop fatty connective tissue after CTX-induced injury.
Elucidation of the detailed mechanisms by which the pheno-
type of mesenchymal progenitors is regulated during muscle
regeneration requires further investigation.
ROLES FOR NONMYOGENIC MESENCHYMAL PROGENITORS
IN STEADY STATE HOMEOSTASIS OF SKELETAL MUSCLE
Nonmyogenic mesenchymal progenitors may have roles in steady
state homeostasis of skeletal muscle. Collagen type VI, along
with the fibrillins, is one of the microfibrillar components of
the ECM. Collagen VI is found in a wide variety of extracellular
matrices, including muscle, skin, tendon, cartilage, interverte-
bral discs, lens, internal organs, and blood vessels. Collagen VI
consists of three products encoded by COL6A1, COL6A2, and
COL6A3. One of each of the three α-chain subunits encoded
by COL6A1, COL6A2, and COL6A3 combine to form the col-
lagen VI monomer. Within the cells, these monomers associate
to form dimers, which pair up into tetramers. These tetramers
are then secreted into the ECM, where they assemble to form
the microfibrillar structures (Bonnemann, 2011). Collagen VI
microfibrils interact with collagen I, collagen IV, and with a vari-
ety of proteoglycans such as biglycan and decorin (Voermans
et al., 2008). Collagen VI occurs in both the basal lamina and the
reticular lamina of muscle, and therefore is an important com-
ponent of endomysium and perimysium of skeletal muscle. The
functional significance of collagen VI in skeletal muscle is evident
as mutations in collagen VI genes cause Ullrich congenital mus-
cular dystrophy (UCMD) and Bethlem myopathy (Bonnemann,
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2011). Disease symptoms are typically more severe in UCMD
than in Bethlemmyopathy. UCMD patients show progressive loss
of individual muscle fibers and muscle mass, and proliferation of
connective and adipose tissue. The precise mechanisms leading
to reduced fiber size are currently unknown. One of the unique
features of collagen VI is its regulated expression. It has been
demonstrated that collagen VI is largely generated by interstitial
mesenchymal cells but not bymyogenic cells (Zou et al., 2008). An
enhancer region of the Col6a1 gene that is required for activation
of transcription in interstitial mesenchymal cells associated skele-
tal muscle was identified (Braghetta et al., 2008). Using reporter
mice that carry this enhancer region, the expression Col6a1 in
interstitial mesenchymal cells but not in myogenic cells was con-
firmed. Interestingly, it has been demonstrated that the expression
of Col6a1 in mesenchymal cells associated with skeletal muscle
is a consequence of an inductive process whereby myogenic cells
activate a specific enhancer region in mesenchymal cells by releas-
ing a diffusible factor; in addition, only mesenchymal cells from
skeletal muscle can respond to this inductive signal (Braghetta
et al., 2008). Although detailed characterization of collagen VI-
producing cells has not been done, their interstitial localization
andmesenchymal nature suggest that these cells are closely related
to mesenchymal progenitors. Thus, it is highly possible that mes-
enchymal progenitors play a key role in supporting muscle fibers
by producing collagen VI under the inductive cue from muscle
cells. Recent study extended the importance of collagen VI by
demonstrating that collagen VI also works as a key component
of the satellite cell niche (Urciuolo et al., 2013).
The roles for mesenchymal progenitors in the maintenance of
muscle fibers have been directly demonstrated by ablating fibrob-
last activation protein-α (FAP)-expressing stromal cells (Roberts
et al., 2013). FAP is the type II membrane dipeptidylpeptidase,
and its expression has been reported to associate with fibroblasts
in the tumor stroma (Garin-Chesa et al., 1990). Note that FAP
differs from FAPs, fibro/adipogenic progenitors, described ear-
lier. FAP+ stromal fibroblasts suppress the immune response to
tumors, and elimination of FAP+ fibroblasts from tumor stroma
unmasks the immune response to cancer and allows the immune
system to attack tumors (Kraman et al., 2010). Therefore, target-
ing FAP+ stromal cells may be a promising strategy to combat
cancer. However, a contraindication to any potential cancer ther-
apy that indiscriminately depletes FAP+ cells might be their pres-
ence in normal tissues. To investigate the occurrence and function
of FAP+ stromal cells in normal tissues, Roberts et al. generated
transgenic mice that permit both the bioluminescent imaging of
FAP+ cells and their conditional ablation (Roberts et al., 2013).
Using this mouse line, FAP+ cells were found to reside in almost
all tissues of the adult mouse. Surprisingly, ablation of FAP+
cells caused significant loss of muscle mass and hypocellularity
of the bone marrow, revealing their essential functions in main-
taining normal muscle mass and hematopoiesis, respectively. The
loss of skeletal muscle mass was attributed to the atrophy of
myofibers, and was accompanied by a persistent decrease in fol-
listatin (Fst) and laminin α2 expression and a transient increase
in atrogin-1 and MuRF1 mRNA levels. Fst is an inhibitor of myo-
statin (Mstn), a negative regulator of muscle mass (McPherron
et al., 1997). Systemic overexpression of Mstn was reported to
induce cachexia (Zimmers et al., 2002), and conversely, Fst over-
expression led to dramatic increase in muscle mass (Lee and
McPherron, 2001). Fst has been shown to inhibit other TGF-
β family members in addition to myostatin to regulate muscle
size (Lee, 2007; Lee et al., 2010). Laminin α2 is a component of
muscle basal lamina and mutations in the laminin α2 gene cause
congenital muscular dystrophy, in which impaired anchoring of
myofibers in the ECM results in impaired membrane stability and
massive muscle fiber degeneration during early infancy (Hayashi
et al., 2001). Laminin α2 deficiency was also reported to induce
the upregulation of key ubiquitin ligases atrogin-1 and MuRF1
(Carmignac et al., 2011). Gene expression analysis of sorted cells
confirmed that FAP+ stromal cells are the major source of both
Fst and laminin α2 in skeletal muscle (Roberts et al., 2013).
Therefore, the ablation of FAP+ stromal cells was directly respon-
sible for the decrease in the expression of Fst and laminin α2 in
muscle, which can be considered to be the basis of the loss of mus-
cle mass and the increase of atrogin-1 and MuRF1. Intriguingly,
FAP+ stromal cells in muscle uniformly express PDGFRα, Sca-
1 and CD90 (Roberts et al., 2013), which are shared cell surface
markers with mesenchymal progenitors (Uezumi et al., 2010),
and both cells are localized to the interstitial spaces of muscle
tissue (Uezumi et al., 2010; Roberts et al., 2013). Thus, FAP+
stromal cells appear nearly identical to mesenchymal progeni-
tors. A further important finding was that these cells undergo
considerable alterations in a cachectic condition (Roberts et al.,
2013). Under a cachectic condition, the FAP-dependent biolu-
minescence in skeletal muscle was significantly reduced, and the
downregulation of Fst and laminin α2 and the upregulation of
atrogin-1 andMuRF1 again accompanied dramatic loss of muscle
mass. Decreased FAP-dependent bioluminescence suggests that
mesenchymal progenitors decreased in number or mesenchymal
progenitors lost the expression of FAP in cachectic muscle. The
latter should be the case because PDGFRα+Sca-1+ cells were
shown to increase in number in cachectic muscle (He et al., 2013).
Collectively, mesenchymal progenitors can play vital roles in the
maintenance of muscle fibers by producing trophic factors such
as collagen VI, Fst, and laminin α2 in a steady physiological con-
dition (Figure 1), and their support functions can be severely
deteriorated in cancer cachexia.
LESSONS FROM BONE MARROW
Mesenchymal stem cells (MSCs) or mesenchymal progenitors
were initially identified in bone marrow. Due to the ease of
their isolation and their extensive proliferation and differenti-
ation potentials, bone marrow MSCs have been expected as a
source of cells for potential use in cell-based therapy and are being
introduced into a clinical setting (Abdallah and Kassem, 2008).
Nevertheless, the actual identity of bone marrow MSCs remains
largely unknown.
Several recent studies documented in vivo functions of MSCs
for constructing the niche of hematopoietic stem cells (HSCs).
Although several cell types in bone marrow are suggested to
play a role in forming the HSC niche (Frenette et al., 2013), we
focus on MSCs in this article. MSCs were reported to support
hematopoiesis and colocalize with HSCs throughout ontogeny
(Mendes et al., 2005). In adult bone marrow, the expression of
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intermediate filament nestin has been shown to identify MSCs
in close contact with the vasculature and HSCs (Mendez-Ferrer
et al., 2010). Perivascular nestin+ MSCs highly express HSC
maintenance genes such as Cxcl12, Scf, and Angpt1, and ablation
of nestin+MSCs rapidly reduces the concentration of HSCs in the
bone marrow. A chemokine Cxcl12 plays a crucial role in main-
taining HSC function and Stem cell factor (Scf), a c-kit ligand, is
required to sustain hematopoiesis. Cxcl12 is produced mainly by
reticular cells scattered throughout the bone marrow, and these
reticular cells were termed Cxcl12-abundant reticular (CAR) cells
(Sugiyama et al., 2006). Using genetically engineered mice in
which a transgene encoding the diphtheria toxin receptor-GFP
fusion protein is knocked into the Cxcl12 locus, CAR cells were
shown to be required for proliferation of HSCs and lymphoid
and erythroid progenitors, as well as maintenance of HSCs in an
undifferentiated state (Omatsu et al., 2010). CAR cells were also
shown to produce most of the Scf and Cxcl12 in the bone mar-
row. Interestingly, CAR cells possess the potential to differentiate
into adipocytes and osteoblasts (Omatsu et al., 2010), indicating
that cells with MSC activity possess HSC niche activity. FAP is
expressed in multipotent bone marrow stromal cells that express
PDGFRα, Sca-1, Cxcl12, and Scf (Roberts et al., 2013; Tran et al.,
2013). Elimination of FAP+ cells has been shown to induce severe
bone marrow hypocellularity (Roberts et al., 2013; Tran et al.,
2013). FAP+ cell-depleted mice showed anemia and suppressed
B-lymphopoiesis and erythropoiesis althoughHSC frequency was
not changed in these mice (Roberts et al., 2013). Leptin recep-
tor (Lepr)–expressing perivascular stromal cells were shown to be
one of the major sources of Scf and required to maintain HSCs
(Ding et al., 2012). However, MSC activity of Lepr+ cells was not
examined. The Cxcl12 gene was knocked out conditionally using
several Cre lines to clarify the importance of Cxcl12 expression in
several different candidate niche cells (Greenbaum et al., 2013).
As a consequence, it was demonstrated that HSCs and common
lymphoid progenitors are maintained by Cxcl12 produced from
Prx1-Cre-targeted cells. The paired-related homeobox gene-1
(Prx1) is expressed in the early limb bud mesenchyme and Prx1-
Cre targets all mesenchymal cells in the limb bud (Logan et al.,
2002). As in muscle, MSCs are enriched in PDGFRα+Sca-1+
cells in bone marrow (Morikawa et al., 2009). Importantly, only
Prx1-targeted PDGFRα+Sca-1+ cells exhibited colony-forming
unit-fibroblast activity and showed osteogenic and adipogenic
differentiation, indicating that this subset is a highly enriched
population of MSCs. Maintenance of committed B cell precur-
sors is dependent on Cxcl12 from CAR cells and/or osteoblasts,
and retention of hematopoietic progenitor cells in the bone
marrow is dependent on Cxcl12 from CAR cells. These results
showed the complexity of the niche microenvironment in the
bone marrow and suggest that distinct stromal niche cells regu-
late specific hematopoietic stem/progenitor populations. Naveiras
et al. reported an interesting finding. They showed that adipocyte-
rich vertebrae of the mouse tail have reduced HSC frequency
compared with adipocyte-free vertebrae of the thorax (Naveiras
et al., 2009). Tail vertebrae of lipodystrophic mice showed normal
HSC frequency, indicating that adipocytes act as negative reg-
ulators of the hematopoietic microenvironment. Because MSCs
can produce adipocytes, this finding suggests the notion that
their aberrant differentiation can negatively affect homeostasis
of parenchymal cells. Among secretory proteins from adipocytes,
adiponectin has been demonstrated to suppress the growth of
myelomonocytic progenitors and the functions of macrophages
(Yokota et al., 2000). Pinho et al. extended these findings to
humans (Pinho et al., 2013). PDGFRα+CD51+ cells in human
bone marrow represent a cell population enriched for MSCs and
capable of expanding human hematopoietic stem and progenitor
cells. These lines of evidence suggest that the intrinsic function of
MSCs in bone marrow is to act as a niche for HSCs.
CONCLUDING REMARKS
Mesenchymal stem/progenitor cells are reported to exist in almost
all organs of both mice and humans (Da Silva Meirelles et al.,
2006; Crisan et al., 2008). Although in vitro multipotency toward
adipogenic, osteogenic, and chondrogenic lineages is a hall-
mark of MSCs, there is no evidence that fat, bone, or carti-
lage are continuously generated in most organs where MSCs
reside. Therefore, it seems unlikely that differentiating into a cer-
tain lineage is an intrinsic in vivo function of MSCs. Instead,
it is tempting to speculate that these cells exert support func-
tions for parenchymal cells of the tissue where they reside, as
reviewed in this paper. Their differentiation might be undesired
in most cases because adipogenic differentiation has a negative
impact on hematopoiesis in bone marrow (Naveiras et al., 2009).
Interestingly, pancreas-derived mesenchymal cells have a greater
ability to support ES cell-derived pancreatic progenitors than the
mesenchymal cells derived from other organs (Sneddon et al.,
2012). Thus, mesenchymal stem/progenitor cells in certain tis-
sues might be specialized to suitably sustain the parenchyma of
that tissue. Because specific expression of collagen VI in muscle
mesenchymal cells requires induction cues from myogenic cells
(Braghetta et al., 2008), such a specializationmight be reciprocally
conducted by parenchymal cells. Exploring the detailed mecha-
nism of parenchymal-mesenchymal interactions is an important
task in a future study.
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